- Presentations
- 4
- Markets
- 1
CellCept is a brand of Mycophenolate marketed by Genentech, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Mycophenolate
- Brand owner
- Genentech
- Registered in
- United States
- Strengths and forms
- 250 mg capsule, 500 mg/20 mL powder for injection, 200 mg/mL powder for oral suspension, 500 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| CellCept 250 mg capsuleOral | Genentech | US FDA | Available on request |
| CellCept 500 mg/20 mL powder for injectionIntravenous | Genentech | US FDA | Available on request |
| CellCept 200 mg/mL powder for oral suspensionOral | Genentech | US FDA | Available on request |
| CellCept 500 mg tabletOral | Genentech | US FDA | Available on request |
Equivalent brands
Other brands of Mycophenolate.
Brand names and trademarks belong to their owners and are used only to identify products.
Request CellCept
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.